Dr Reddys Laboratories informs about press release

29 Jan 2016 Evaluate

Dr Reddys Laboratories has informed about a press release dated January 29, 2016 titled ‘Dr. Reddy’s Laboratories Receives FDA approval for ZEMBRACE SymTouch (sumatriptan succinate) Injection for the acute treatment of migraines in adults’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1170.15 3.70 (0.32%)
20-Jan-2026 11:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1653.90
Dr. Reddys Lab 1170.15
Cipla 1390.00
Zydus Lifesciences 879.85
Lupin 2165.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×